Insights Into Myelofibrosis (MF) 2024
Perspectives on drivers in treatment decisions in the management of MF
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Srinivas Tantravahi, MBBS
University of Utah Health, Salt Lake City, UT, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Pankit Vachhani, MD
O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Lindsey Lyle, MS, PA-C
Aurora Medical Center of Oshkosh, Omro, WI, USA
Faculty Chair
Lindsey Lyle, MS, PA-C
Aurora Medical Center of Oshkosh, Omro, WI, USA
Faculty Chair
Pankit Vachhani, MD
O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA
Faculty Chair
Pankit Vachhani, MD
O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA
Faculty Chair
Aaron Gerds, MD
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Faculty Chair
Kathryn Johnson, NP
University of California, San Francisco, CA, USA
Faculty Chair
Stephen Oh, MD, PhD
Washington University, St Louis, MO, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Raajit Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
Lindsey Lyle, MS, PA-C
Aurora Medical Center of Oshkosh, Omro, WI, USA
Faculty Chair
Raajit Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Kristi Orbaugh, MSN, RNP, AOCNP
Community Hospital Oncology Physicians, Indianapolis, IN, USA
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Raajit Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
Karolina Faysman, MSN, AOCNP, DNP
Bowyer Oncology Center, Los Angeles, CA, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Stephen Oh, MD, PhD
Washington University, St Louis, MO, USA
Faculty Chair
Stephen Oh, MD, PhD
Washington University, St Louis, MO, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Aaron Gerds, MD
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Faculty Chair
Raajit Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
Kristi Orbaugh, MSN, RNP, AOCNP
Community Hospital Oncology Physicians, Indianapolis, IN, USA
Faculty Chair
Abdulraheem Yacoub, MD
University of Kansas Medical Center, Kansas City, KS, USA
Faculty Chair
Bart Scott, MD
University of Washington Medical Center, Seattle, WA, USA
Faculty Chair
Raajit Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
Faculty Chair
Bart Scott, MD
Fred Hutchinson Cancer Center, Seattle, WA, USA
Faculty Chair
Lindsey Lyle, MS, PA-C
Aurora Medical Center of Oshkosh, Omro, WI, USA
Faculty Chair
John Mascarenhas, MD
Mount Sinai, New York, NY, USA
More Information
- San Diego, CA
- California
MORE INFORMATION
- Seattle, WA
- Idaho, Montana, Northern California, Oregon, Washington, Wyoming
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of MF
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained
- Current management and emerging challenges in MF
- Current therapy paradigms for MF
- Unmet needs and emerging paradigms
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
